MedPath

Aplicare Povidone-Iodine

4801 Aplicare Povidone-Iodine

Approved
Approval ID

91aef86d-ce8b-45be-bce9-74450292e0cd

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Sep 2, 2025

Manufacturers
FDA

Aplicare Products, LLC

DUNS: 081054904

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Povidone-Iodine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52380-4801
Application Number505G(a)(3)
Product Classification
M
Marketing Category
C200263
G
Generic Name
Povidone-Iodine
Product Specifications
Route of AdministrationTOPICAL
Effective DateSeptember 2, 2025
FDA Product Classification

INGREDIENTS (6)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
NONOXYNOL-9Inactive
Code: 48Q180SH9T
Classification: IACT
POVIDONE-IODINEActive
Quantity: 10 mg in 1 mL
Code: 85H0HZU99M
Classification: ACTIM

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 4/8/2015

Package Label

label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 4/29/2015

Use

  • • antiseptic skin preparation
  • • single use when used for patient preoperative skin preparation

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 1/20/2010

Purpose

Antiseptic

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 1/20/2010

Active ingredient

Povidone-iodine 10%

(equivalent to 1% available iodine)

WARNINGS SECTION

LOINC: 34071-1Updated: 4/29/2015

Warnings

*For external use only *Avoid "pooling" beneath patient. Prolonged exposure to wet solution may cause skin irritation.

Do not use

  • • in the eyes
  • • on individuals allergic or sensitive to iodine

Ask a doctor before use if injuries are

  • • deep puncture wounds
  • • serious burns

Stop use and ask a doctor if

  • • infection occurs
  • • redness, irritation, swelling or pain persists or increases

Keep out of reach of children.

In case of accidental ingestion, seek professional assistance or consult a poison control center immediately.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 4/29/2015

Directions

apply topically as needed

OTHER SAFETY INFORMATION

LOINC: 60561-8Updated: 4/8/2015

Other information

  • • not made with natural rubber latex
  • • for hospital or professional use only

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 4/8/2015

Inactive ingredients

citric acid, disodium phosphate, nonoxynol-9, sodium hydroxide, water

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 4/8/2015

Questions or comments?

www.medline.com 1 800-Medline

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 12/1/2021

Manufacturing Information

Manufactured in USA by Medline Industries, LP,

Three Lakes Drive, Northfield, IL 60093 USA.

www.medline.com 1-800-Medline

REF: APL82344K

V1 RG24HND

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.